GFACX
Price
$73.86
Change
-$0.24 (-0.32%)
Updated
Jun 2 closing price
Net Assets
337.53B
USLCX
Price
$29.73
Change
-$0.30 (-1.00%)
Updated
Jun 2 closing price
Net Assets
1.27B
Interact to see
Advertisement

GFACX vs USLCX

Header iconGFACX vs USLCX Comparison
Open Charts GFACX vs USLCXBanner chart's image
GFACX vs USLCX Comparison Chart in %
View a ticker or compare two or three
VS
GFACX vs. USLCX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Hold and USLCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 338B vs. USLCX (1.27B). GFACX (0.00) and USLCX (0.00) have matching dividends . GFACX was incepted earlier than USLCX: GFACX (25 years) vs USLCX (24 years). USLCX (1.89) is less costly to investors than GFACX (1.35). GFACX (32.00) and USLCX (32.00) have comparable annual turnover. GFACX has a lower initial minimum investment than USLCX: GFACX (250) vs USLCX (1000). GFACX annual gain was more profitable for investors over the last year : 12.09 vs. USLCX (-31.77). GFACX return over 5 years is better than : 14.79 vs. USLCX (-41.79).
GFACXUSLCXGFACX / USLCX
Total Expense Ratio1.351.8872%
Annual Report Gross Expense Ratio1.351.8971%
Fund Existence25 years24 years-
Gain YTD10.104-0.826-1,224%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets338B1.27B26,551%
Annual Yield % from dividends0.000.00-
Returns for 1 year12.09-31.77-38%
Returns for 3 years44.36-26.43-168%
Returns for 5 years14.79-41.79-35%
Returns for 10 years88.17-16.49-535%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CSHAX12.600.20
+1.61%
NYLI Cushing® MLP Premier Class A
RYOAX61.16N/A
N/A
Rydex Biotechnology H
SWTSX18.32N/A
N/A
Schwab Total Stock Market Index
PHSKX37.47N/A
N/A
Virtus KAR Mid-Cap Growth A
JLPYX25.76N/A
N/A
JPMorgan US Large Cap Core Plus R6